Healthcare Capital Corp Class A HCCC 深 沪
已收盘 03-07 16:00:00 美东时间
12.74
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 12.74
- 总市值 4.38亿
- 52周最高 14.78
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.20
- 委 比 0.00%
- 总股本 3437.50万
- 历史最高 14.78
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.20
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UPDATE: Vor Bio Announces $150M Private Placement To Sell 13,876,032 Shares Of Its Common Stock At A Price Of $10.81 Per Share To A Select Group Of Institutional And Accredited Healthcare Specialist Investors
Vor Bio (NASDAQ:VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a securities purchase agreement to sell 13,876,032 shares of its
12-15 21:52
Vor Bio announces $150M private placement
Vor Bio (NASDAQ:VOR) announced on Monday that it has entered into a securities purchase agreement to sell 13.87M shares of its common stock at a price of $10.81 per share in a private placement. The c...
12-15 21:45
What's Happening With Crescent Biopharma Stock Today?
Cresent Biopharma shares were trading higher Thursday but have since reversed and begun trading lower after the company announced a partnership with Sichuan Kelun-Biotech Biopharmaceutical.
12-05 00:29
Crescent Biopharma Secures $185M Private Placement; Investors To Purchase 13.8M Ordinary Shares At $13.41 Or Pre-Funded Warrants At $13.409
Private Placement FinancingCrescent also announced today that it entered into a securities purchase agreement for a private investment of securities to institutional and other accredited investors that is expected to
12-04 19:38
Galecto Announces Acquisition of Damora Therapeutics
<p>Galecto完成对Damora的收购并获得2.85亿美元私募融资，以推进mutCALR靶向疗法DMR-001，计划于2027年完成Phase 1临床数据，支持治疗 ET 和 MF 等 MPNs。</p>
11-10 12:00
Maze Therapeutics Secures $150M In Oversubscribed Private Placement
Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced it has entered into a
09-11 19:37
科创板创新药企半年盘点：首创新药密集获批 步入“增收缩亏”良性增长阶段
转自：新华财经 新华财经上海9月9日电（记者杜康）科创板支持了一批创新药企业上市，为一批重磅医学成果的落地提供了资本支持。近日，2025年世界肺癌大会（WCL...
09-09 21:16
Olympus Partners with Revival Healthcare for Endoluminal Robotics Venture
Olympus ( ($JP:7733) ) has provided an announcement. Olympus Corporation has an...
07-25 15:25
总交易额42.3亿美元，荣昌生物与纳斯达克上市公司Vor Biopharma就泰...
REMEGEN 美国东部时间6月25日，荣昌生物宣布，将公司具有自主知识产权的泰它西普有偿许可给美国纳斯达克上市公司Vor Biopharma Inc.（以下简...
06-26 08:22
ORIC Pharma Announces $125M Private Placement At 18% Premium
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital,
05-29 04:17
